Latest AI and machine learning research in bipolar disorder for healthcare professionals.
Glycogen synthase kinase-3β (GSK3β) has emerged as one of the most thoroughly validated therapeutic targets in modern drug discovery, with dysregulation implicated in neurodegenerative diseases, metabolic disorders, cancer, psychiatric conditions, and inflammatory pathologies. This review provides a comprehensive and critical overview of recent advances in GSK3β inhibitor design, encompassing ATP-...
We integrate ab initio crystal structure prediction with universal machine learning interatomic potentials (UMA and Orb-v3) to determine challenging metal organic compound structures. Our framework successfully resolves the previously unknown, technologically significant crystal structures of lithium phenolate, sodium cyclohexanolate, and lithium-benzimidazol-2-one, accelerating materials developm...
BACKGROUND: Major depressive disorder (MDD) and treatment-resistant depression (TRD) are heterogeneous conditions in which key clinical details are sp...
Accurate estimation of State of Charge (SoC) and State of Health (SoH) values in battery management systems is crucial for maintaining energy efficien...
INTRODUCTION: Socially assistive humanoid robots have emerged as promising tools for enhancing mood, engagement, and social connection in clinical and...
Individuals with schizophrenia demonstrated impaired inhibitory control and apathy symptoms, which are characterized by a reduction in self-initiated ...
Lithium-based batteries are fundamental to modern energy storage systems, yet their safety remains a critical challenge due to risks such as thermal r...
OBJECTIVE: Epilepsy affects ~1% of the global population and often requires lifelong antiseizure medication (ASM) therapy. Valproic acid (VPA) is a co...
The transition to a sustainable energy future requires electrochemical storage systems that surpass conventional lithium-ion batteries. The lithium-su...
The assessment of depression severity still relies primarily on subjective rating scales, with a lack of objective quantitative biomarkers. This study...
Major depressive disorder (MDD) is highly prevalent among adolescents, but its neurobiological mechanisms remain unclear. Neuroimaging studies have sh...
Diminished drive is one of the core symptoms of major depressive disorder (MDD) diagnosis, yet its underlying neural mechanisms remain elusive, primar...
The increasing use of nickel-rich (Ni ≥ 0.6) layered oxide cathodes in lithium-ion batteries creates an urgent need for recycling, for which existing ...
The brain age gap (BAG), the difference between magnetic resonance imaging-predicted brain age and chronological age, is a proposed marker of neurobio...
Major depressive disorder (MDD) may exhibit deficits in the inhibition of negative information. This study investigated whether there are inhibition d...
BACKGROUND: Individuals with bipolar disorder (BD) are at increased risk for major adverse cardiovascular events. Recent evidence suggests that the di...
BACKGROUND: With the rapidly aging population, mental health among older adults has received growing attention. Although the likelihood of experiencin...
Major Depressive Disorder (MDD) is a highly prevalent mental health condition, and a deeper understanding of its neurocognitive foundations is essenti...
Currently, artificial intelligence (AI) is clinically relevant to mood and anxiety care, but the evidence base is uneven across use cases. This narrat...
BACKGROUND: Early prediction of depressive and anxiety disorders is challenging due to substantial heterogeneity in risk pathways. Conventional machin...